← Eichor
Condition: Gpc3 Positive Hepatocellular Carcinoma Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Gpc3 Positive Hepatocellular Carcinoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

TC-G203 for Patients With GPC3-Positive Advanced Solid Tumors
EARLY_Phase 1 · 2 location(s) · Beijing GoBroad Hospital · NCT07242417Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells
Phase 1 · 1 location(s) · Baylor College of Medicine · NCT06198296Clinical Study of SN301A Injection in the Treatment of Hepatocellular Carcinoma
EARLY_Phase 1 · 1 location(s) · Shanghai General Hospital, Shanghai Jiao Tong University Sch · NCT06652243An Open-Label, Phase I Clinical Trial of Super CAR-T With GPC3-Positive Advanced Hepatocellular Carcinoma
Phase 1 · 1 location(s) · Guangzhou FineImmune Biotechnology Co., LTD. · NCT07493044Phase I Study of OriC902 in Treatment of Advanced HCC
Phase 1 · 2 location(s) · Peking University · NCT06891742A Phase 1 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants Wit
Phase 1 · 47 location(s) · BeOne Medicines · NCT06427941A Study to Evaluate the Tolerability, Safety, and PK of AST-201 in Patients With GPC3-positive Advanced Solid Tumors
Phase 1 · 4 location(s) · Aptamer Sciences, Inc. · NCT06687941A Study to Evaluate CG-102-12C in Glypican-3 (GPC3) Positive Advanced Hepatocellular Carcinoma (HCC)
NA · 2 location(s) · Zhejiang University · NCT07039201
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.